Westover Capital Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-17,790
| Closed | -$1.47M | – | 79 |
|
|
2016
Q1 | $1.47M | Sell |
17,790
-1,674
| -9% | -$138K | 1.24% | 32 |
|
|
2015
Q4 | $2.04M | Sell |
19,464
-298
| -2% | -$31.2K | 1.7% | 22 |
|
|
2015
Q3 | $2.08M | Sell |
19,762
-706
| -3% | -$74.3K | 1.79% | 21 |
|
|
2015
Q2 | $2.8M | Sell |
20,468
-1,353
| -6% | -$185K | 2.23% | 16 |
|
|
2015
Q1 | $2.72M | Sell |
21,821
-66
| -0.3% | -$8.22K | 2.2% | 14 |
|
|
2014
Q4 | $1.98M | Sell |
21,887
-1,724
| -7% | -$156K | 1.7% | 23 |
|
|
2014
Q3 | $1.7M | Buy |
23,611
+5,562
| +31% | +$401K | 1.39% | 28 |
|
|
2014
Q2 | $1.12M | Buy |
18,049
+1,496
| +9% | +$93.1K | 0.95% | 41 |
|
|
2014
Q1 | $1.13M | Hold |
16,553
| – | – | 1.05% | 37 |
|
|
2013
Q4 | $1.17M | Buy |
+16,553
| New | +$1.17M | 1.11% | 36 |
|